Having seen that IFN-γ treatment upregulated PD-L1 expression (Figure 1C) and increased sensitivity to ADCC (Figure 2), we sought to establish a model where IFN-γ would be produced by tumor antigen-specific CD8+ T cells. Here, IFNG is linked to neoplasm.